Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKesson
US Army
Healthtrust
Federal Trade Commission
Cerilliant
Harvard Business School
Argus Health
Deloitte

Generated: January 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Nimotuzumab

« Back to Dashboard

US Patents for Nimotuzumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Nimotuzumab ➤ Sign Up Binding molecules specific for HER3 and uses thereof MEDIMMUNE, LLC (Gaithersburg, MD) ➤ Sign Up
Nimotuzumab ➤ Sign Up Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Sign Up
Nimotuzumab ➤ Sign Up Anti-EGFR activatable antibodies CytomX Therapeutics, Inc. (South San Francisco, CA) ➤ Sign Up
Nimotuzumab ➤ Sign Up Substituted urea derivatives and pharmaceutical uses thereof SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) ➤ Sign Up
Nimotuzumab ➤ Sign Up Azabicyclo derivatives, process for preparation thereof and medical use thereof Shanghai Haiyan Pharmaceutical Technology Co., Ltd. (Shanghai, CN) Yangtze River Pharmaceutical Group Co., Ltd. (Jiangsu, CN) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Nimotuzumab

Drugname Country Document Number Estimated Expiration Related US Patent
Nimotuzumab Australia 2012340766 2031-11-23 ➤ Sign Up
Nimotuzumab Brazil 112014012539 2031-11-23 ➤ Sign Up
Nimotuzumab Canada 2856297 2031-11-23 ➤ Sign Up
Nimotuzumab China 104093743 2031-11-23 ➤ Sign Up
Nimotuzumab Colombia 7051008 2031-11-23 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Cipla
Cerilliant
Colorcon
AstraZeneca
Julphar
QuintilesIMS
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.